Header cover image

Swiss Pharmaceuticals & Biotech Pure Equity Growth

Results

1

1 new

Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.

1 companies

Kuros Biosciences

Market Cap: CHF 738.8m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

New

KURN

CHF 20.50

7D

-3.8%

1Y

-17.3%